FDA advisory committee unanimously recommended Moderna's mRNA flu vaccine for adults 50+, marking its first new vaccine review since 2023. The vaccine offers potentially stronger, faster-adaptable protection against flu strains.
FDA panel endorses Moderna mRNA flu vaccine
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →